Inventaire - your friends and communities are your best library

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

Author

Jørgen Vestbo

Published in: The Lancet

Date of publication: February 1, 2003

Language: English

Main subject: chronic obstructive pulmonary disease

Bibliographic databases:

Cites articles 25

Date

Title

Authors

June 1, 1992

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire
August 1992

Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation
March 1993

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society
May 1, 1994

Reliability and validity of the chronic respiratory questionnaire (CRQ).
August 1, 1995

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force
April 1, 1997

Quality of life changes in COPD patients treated with salmeterol
January 1, 1997

Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease
May 1, 1998

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease
November 1, 1998

Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. SLMT02 Italian Study Group

,
March 1, 1998

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
April 1, 1999

Efficacy of salmeterol xinafoate in the treatment of COPD
June 1, 1999

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease
May 1, 1999

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial
November 1, 1999

An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting
July 1, 1999

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
February 1, 2000

Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease
May 13, 2000

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
April 1, 2001

Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease
September 1, 2001

Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease
July 1, 2001

Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.
April 2001

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary
June 1, 2001

Do long-acting beta2-adrenoceptor agonists enhance the anti-inflammatory effect of glucocorticoids in asthma?
March 1, 2001

Exercise capacity predicts health status in alpha(1)-antitrypsin deficiency
April 1, 2002

Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD.
January 1, 2002

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids

Article -

Welcome to inventaire

The library of your friends and communities

You are offline